ARGULIN
associated with 1 other trademarks
Pharmaceuticals for cancer treatment, excluding for treatment of blood cancers; pharmaceutical preparations for treating diabetes; pharmaceutical prep...

Words that describe this trademark:

diabetes pharmaceutical  pharmaceutical preparations  cancer treatment  treating diabetes  preparations  pharmaceuticals  treatment  substances 

Serial Number:

97160775

Mark:

ARGULIN

Status:

First Extension-Granted

Status Date:

02-19-2024

Filing Date:

Registration Number:

N/A

Registration Date:

05-16-2022

Goods and Services:

Pharmaceuticals for cancer treatment, excluding for treatment of blood cancers; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of obesity; medical and veterinary preparations, namely, anticancer drugs and compounds for treating cancer, excluding for treatment of blood cancers, anti-diabetic pharmaceuticals and preparations, anti-obesity pharmaceuticals and preparations Providing consumer information services relating to the selection of medical products Medical services; medical services in the field of oncology; medical diagnostic testing services; medical clinic services; conducting of medical examinations; medical consultation regarding use and effectiveness of medical products; medical information; medical advisory services; medical analysis services, namely, medical analysis services for cancer diagnosis and prognosis; medical services in the field of diabetes; medical care Medical and pharmacological research services; research on the subject of pharmaceuticals; scientific investigations for medical purposes; scientific research for medical purposes; development of pharmaceutical preparations and medicines

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

01-24-2023

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

HEAD, JOHNSON, KACHIGIAN & WILKINSON, PC

Correspondent Name:

Recent Trademark filings by this company